entity,start_date,end_date,context,AARSRAPPORT_html,AARSRAPPORT_pdf,AARSRAPPORT_xml,AddressOfAuditorCountry,AddressOfAuditorDistrictName,AddressOfAuditorPostCodeIdentifier,AddressOfAuditorStreetBuildingIdentifier,AddressOfAuditorStreetName,AddressOfFinancialDistrictName,AddressOfFinancialPostCodeIdentifier,AddressOfFinancialStreetBuildingIdentifier,AddressOfFinancialStreetName,AddressOfReportingEntityDistrictName,AddressOfReportingEntityPostCodeIdentifier,AddressOfReportingEntityStreetBuildingIdentifier,AddressOfReportingEntityStreetName,AddressOfSubmittingEnterprisePostcodeAndTown,AddressOfSubmittingEnterpriseStreetAndNumber,AddresseeOfAuditorsReportOnAuditedFinancialStatements,ClassOfReportingEntity,ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement,ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults,DateOfApprovalOfAnnualReport,DateOfApprovalOfReport,DateOfFoundationOfReportingEntity,DateOfGeneralMeeting,DescriptionOfAuditor,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfExternalExpenses,EmailOfAuditor,IdentificationNumberCvrOfAuditFirm,IdentificationNumberCvrOfReportingEntity,IdentificationNumberCvrOfSubmittingEnterprise,IdentificationNumberOfAuditor,IdentificationOfApprovedAnnualReport,InformationOnTypeOfSubmittedReport,InvestmentsGross,ManagementsStatementAboutManagementsReview,NameAndSurnameOfAuditor,NameAndSurnameOfChairmanOfGeneralMeeting,NameOfAuditFirm,NameOfFinancialInstitution,NameOfReportingEntity,NameOfSubmittingEnterprise,PlaceOfSignatureOfStatement,PrecedingReportingPeriodStartDate,PredingReportingPeriodEndDate,RecognisedButNotOwnedAssets,RecommendationForApprovalOfAnnualReportByGeneralMeeting,RegisteredOfficeOfReportingEntity,RelatedEntityName,RelatedEntityRegisteredOffice,ReportingPeriodEndDate,ReportingPeriodStartDate,ShareHeldByEntityOrConsolidatedEnterprisesInRelatedEntity,SignatureOfAuditorsDate,SignatureOfAuditorsPlace,TelephoneNumberOfAuditor,TypeOfAuditorAssistance,_id,_index,_score,cvrNummer,indlaesningsId,indlaesningsTidspunkt,offentliggoerelsesTidspunkt,offentliggoerelsestype,omgoerelse,regNummer,regnskabsperiode_slutDato,regnskabsperiode_startDato,sagsNummer,sidstOpdateret,Equity,ProfitLoss,AdditionsToInvestments,GrossProfitLoss,InterestExpenseAssignedToGroupEnterprises,OtherFinanceExpenses,OtherFinanceIncome,ProfitLossFromOrdinaryActivitiesBeforeTax,ProfitLossFromOrdinaryOperatingActivities,ResultsFromNetFinancials,IncreaseOfCapital,TransferredFromSharePremium,ValueAdjustmentsOfEquity,LongtermInvestmentsAndReceivables,Assets,CashAndCashEquivalents,ContributedCapital,CurrentAssets,LiabilitiesAndEquity,LiabilitiesOtherThanProvisions,LongtermInvestmentsInGroupEnterprises,NoncurrentAssets,RetainedEarnings,ShorttermLiabilitiesOtherThanProvisions,ShorttermPayablesToGroupEnterprises,ShorttermReceivables,ShorttermTaxReceivables,ShorttermTradePayables,GrossResult,NameAndSurnameOfMemberOfSupervisoryBoard,NameAndSurnameOfMemberOfExecutiveBoard
34580367,2017-01-01,2017-01-01,c172,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,13457694.0,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34580367,2017-01-01,2017-01-01,c704,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,89922.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34580367,2017-01-01,2017-01-01,c725,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,13015535.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34580367,2017-01-01,2017-12-31,c120,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,-105098.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34580367,2017-01-01,2017-12-31,c174,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,,8184288.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34580367,2017-01-01,2017-12-31,c3,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,-105098.0,,-65689.0,39587.0,39587.0,178.0,-105098.0,-65689.0,39000.0,,,,,,,,,,,,,,,,,,,,,
34580367,2017-01-01,2017-12-31,c705,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,,,,,,,,,,1034.0,,,,,,,,,,,,,,,,,,,,
34580367,2017-01-01,2017-12-31,c711,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,,,,,,,,,,,8183076.0,-8183076.0,,,,,,,,,,,,,,,,,,
34580367,2017-01-01,2017-12-31,c726,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,-105098.0,,,,,,,,,,,8183076.0,,,,,,,,,,,,,,,,,,
34580367,2017-12-31,2017-12-31,c176,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,21641982.0,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,,,,,,,,,,,,,21641982.0,,,,,,,,,,,,,,,,,
34580367,2017-12-31,2017-12-31,c4,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,21184469.0,,,,,,,,,,,,,21641982.0,23759941.0,630627.0,90956.0,2117959.0,23759941.0,2575472.0,21641982.0,21641982.0,21093513.0,2575472.0,2549972.0,1487332.0,1487332.0,25500.0,,,
34580367,2017-12-31,2017-12-31,c706,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,90956.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34580367,2017-12-31,2017-12-31,c727,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,21093513.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34580367,2018-01-01,2018-01-01,c171,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,21641982.0,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34580367,2018-01-01,2018-01-01,c177,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,90956.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34580367,2018-01-01,2018-01-01,c195,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,21093513.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34580367,2018-01-01,2018-12-31,c1,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,-445270.0,,-344300.0,101754.0,101754.0,784.0,-445270.0,-344300.0,101000.0,,,,,,,,,,,,,,,,,,,,,
34580367,2018-01-01,2018-12-31,c119,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,-445270.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34580367,2018-01-01,2018-12-31,c173,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,,45448772.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34580367,2018-01-01,2018-12-31,c178,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,,,,,,,,,,5892.0,,,,,,,,,,,,,,,,,,,,
34580367,2018-01-01,2018-12-31,c181,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,,,,,,,,,,,45442096.0,-45442096.0,,,,,,,,,,,,,,,,,,
34580367,2018-01-01,2018-12-31,c196,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,-445270.0,,,,,,,,,,,45442096.0,,,,,,,,,,,,,,,,,,
34580367,2018-01-01,2018-12-31,c245,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,-269000.0,,,,,,,-252000.0,-17000.0,,,,,,,,,,,,,,,,,,,-252000.0,,
34580367,2018-01-01,2018-12-31,c248,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,8000.0,,,,,,,-13000.0,20000.0,,,,,,,,,,,,,,,,,,,-13000.0,,
34580367,2018-01-01,2018-12-31,c251,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,-4000.0,,,,,,,-16000.0,12000.0,,,,,,,,,,,,,,,,,,,-16000.0,,
34580367,2018-01-01,2018-12-31,c31,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mads Daugaard,
34580367,2018-01-01,2018-12-31,c460,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34580367,2018-01-01,2018-12-31,c47,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Peter SchrÃ¶cksnadel,
34580367,2018-01-01,2018-12-31,c48,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Poul Henrik Bredahl SÃ¸rensen,
34580367,2018-01-01,2018-12-31,c49,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Ali El-Salanti,
34580367,2018-01-01,2018-12-31,c50,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Thor Grundtvig Theander,
34580367,2018-01-01,2018-12-31,c51,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mai-Britt Zocca,
34580367,2018-01-01,2018-12-31,c69,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Thor Grundtvig Theander
34580367,2018-01-01,2018-12-31,c70,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Ali El-Salanti
34580367,2018-01-01,2018-12-31,c80,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mads Daugaard
34580367,2018-01-01,2018-12-31,c87,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34580367,2018-12-31,2018-12-31,c175,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,67090754.0,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,,,,,,,,,,,,,,67090754.0,,,,,,,,,,,,,,,,,
34580367,2018-12-31,2018-12-31,c179,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,96848.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34580367,2018-12-31,2018-12-31,c197,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,66090339.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34580367,2018-12-31,2018-12-31,c247,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,13105000.0,,,,,,,,,,,,,,14089000.0,,,,,,,,,,,,,,,,
34580367,2018-12-31,2018-12-31,c250,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,5191000.0,,,,,,,,,,,,,,5395000.0,,,,,,,,,,,,,,,,
34580367,2018-12-31,2018-12-31,c253,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,1787000.0,,,,,,,,,,,,,,1919000.0,,,,,,,,,,,,,,,,
34580367,2018-12-31,2018-12-31,c461,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
34580367,2018-12-31,2018-12-31,c6,,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzhhLzZhLzQ0LzZkL2ZjMzYtNDZiYS1iYjFiLTJlNjRkZjM4ZDEwMA.pdf,http://regnskaber.virk.dk/76308543/ZG9rdW1lbnRsYWdlcjovLzAzLzcyLzRkLzU5LzMwL2Q0MGEtNDg4NC05YmM2LTZhZDZlYjFiNGQzYw.xml,Danmark,Glostrup,2600.0,56.0,Hovedvejen,KÃ¸benhavn K,1090.0,2.0,Holmens Kanal,KÃ¸benhavn N,2200.0,3.0,"c/o COBIS, Ole MaalÃ¸es Vej","2600, Glostrup","Hovedvejen, 56",kapitalejerne,Regnskabsklasse B,The annual report has been presented in accordance with the Danish Financial Statements Act.,"We consider the accounting policies used appropriate, and in our opinion the annual accounts provide a true and fair view of the company's assets and liabilities and its financial position at 31 December 2018 and of the company's results of its activities in the financial year 1 January to 31 December 2018.",2019-05-18,2019-05-18,2012-05-09,2019-05-18,Statsautoriseret revisor,Other external costs comprise costs for administration.,pkf@pkf.dk,14119299.0,34580367.0,14119299.0,mne29389,The board of directors and the executive board have today presented the annual report of Oncomal ApS for the financial year 1 January to 31 December 2018.,Ãrsrapport,,We are of the opinion that the management's review includes a fair description of the issues dealt with.,Kasper Vindelev,Ali El-Salanti,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",Danske Bank,Oncomal ApS,"PKF Munkebo Vindelev, Statsautoriseret Revisionsaktieselskab",KÃ¸benhavn N,2017-01-01,2017-12-31,0.0,The annual report is recommended for approval by the general meeting.,KÃ¸benhavns Kommune,Var2 Pharmaceuticals ApS,Copenhagen,2018-12-31,2018-01-01,93.57,2019-05-18,Glostrup,43 96 06 56,RevisionspÃ¥tegning,urn:ofk:oid:27212290,indberetninger-20180424,2.5118417999999996,34580367.0,AWrkYwh5RYGX6_YTH8t0,2019-05-23T11:11:59.877Z,2019-05-23T11:10:55.867Z,regnskab,0.0,,2018-12-31,2018-01-01,X19-BG-33-XH,2019-05-23T11:10:56.176Z,66187187.0,,,,,,,,,,,,,67090754.0,70218226.0,1765128.0,96848.0,3127472.0,70218226.0,4031039.0,67090754.0,67090754.0,66090339.0,4031039.0,4015008.0,1362344.0,1362344.0,16031.0,,,
